(Q41751197)

8 October 2017

1 reference

title

The sulfonylurea controversy: more questions from the heart (English)

1 reference

8 October 2017

Brady PA

1

1 reference

8 October 2017

Terzic A

series ordinal

2

1 reference

8 October 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

Journal of the American College of Cardiology

8 October 2017

published in

1 reference

8 October 2017

volume

31

1 reference

8 October 2017

issue

5

1 reference

8 October 2017

page(s)

950-956

1 reference

Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood institute

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

The sulfonylurea receptor

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Cardiac ATP-sensitive K channels: regulation by intracellular nucleotides and K channel-opening drugs

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

The hypoglycemic sulfonamides: history and development of the problem from 1942 to 1955

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP)

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Vascular complications and long-term administration of oral hypoglycemic agents in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Sulfonylureas in NIDDM.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

The ABCs of ATP-sensitive potassium channels: more pieces of the puzzle

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Sulfonylurea receptors and mechanism of sulfonylurea action

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

ATP-regulated K channels in cardiac muscle

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Lilly Lecture 1994. The beta-cell in diabetes: from molecular genetics to clinical research

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Intracellular ATP directly blocks K channels in pancreatic B-cells

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Role of voltage- and Ca2( )-dependent K channels in the control of glucose-induced electrical activity in pancreatic B-cells

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Sweet news for hypoglycemic babies

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Glibenclamide specifically blocks ATP-sensitive K channel current in atrial myocytes of guinea pig heart

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

On the mechanism of inhibition of KATP channels by glibenclamide in rat ventricular myocytes.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Sulfonylureas, ATP-sensitive K channels, and cellular K loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Metabolic regulation of cardiac ATP-sensitive K channels

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Actin microfilament disrupters enhance K(ATP) channel opening in patches from guinea-pig cardiomyocytes.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Reversal of the ATP-liganded state of ATP-sensitive K channels by adenylate kinase activity.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Ligand-insensitive state of cardiac ATP-sensitive K channels. Basis for channel opening

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

ATP-sensitive potassium channels and myocardial preconditioning

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Coronary cyclic flow variations "precondition" ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptors.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

G proteins activate ATP-sensitive K channels by antagonizing ATP-dependent gating

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

The pharmacology of ATP-sensitive potassium channels

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

K channel openers and 'natural' cardioprotection

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Glibenclamide, an ATP-sensitive K channel blocker, inhibits cardiac cAMP-activated Cl- conductance

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Interruption of Escherichia coli heat-stable enterotoxin-induced guanylyl cyclase signaling and associated chloride current in human intestinal cells by 2-chloroadenosine.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Glibenclamide inhibits a voltage-gated K current in the human neuroblastoma cell line SH-SY5Y.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Direct action of BRL 38227 and glibenclamide on intracellular calcium stores in cultured airway smooth muscle of rabbit

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Does ischemic preconditioning occur in patients?

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K channel blocker.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Effects of the presence or absence of preceding angina pectoris on left ventricular function after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Is warm-up in angina ischaemic preconditioning?

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Improvement in ischemic parameters during repeated exercise testing: a possible model for myocardial preconditioning

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Ischemic preconditioning in cardiac surgery: a word of caution

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: Experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

The prognostic significance of angina pectoris preceding the occurrence of a first acute myocardial infarction in 4166 consecutive hospitalized patients

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection?

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: implications for the design of randomized trials of acute intervention

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Operative Condition–Dependent Response of Cardiac ATP-Sensitive K Channels Toward Sulfonylureas

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Dualistic behavior of ATP-sensitive K channels toward intracellular nucleoside diphosphates

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Dual effect of glyburide, an antagonist of KATP channels, on metabolic inhibition-induced Ca2 loading in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Role of ATP-sensitive K channel current in ischemic arrhythmias

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Electrophysiological effects of ATP sensitive potassium channel modulation: implications for arrhythmogenesis

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Simulation of action potentials from metabolically impaired cardiac myocytes. Role of ATP-sensitive K current.

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

In vitro cardiac models of dog Purkinje fibre triggered and spontaneous electrical activity: effects of nicorandil

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Antiarrhythmic actions of the ATP-regulated K current activated by pinacidil

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

The Effects of the ATP-Dependent Potassium Channel Antagonist, Glyburide, on Coronary Blood Flow and Susceptibility to Ventricular Fibrillation in Unanesthetized Dogs

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Reduction of ischemic K loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Effectiveness of glibenclamide on myocardial ischemic ventricular arrhythmias in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Effects of ATP-sensitive K channel blockers on the action potential shortening in hypoxic and ischaemic myocardium

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

ATP-regulated K channels protect the myocardium against ischemia/reperfusion damage

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Role of ATP-sensitive K channel on ECG ST segment elevation during a bout of myocardial ischemia. A study on epicardial mapping in dogs

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Antiarrhythmic Effect of Repeated Coronary Occlusion During Balloon Angioplasty

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Are ATP sensitive potassium channels involved in the pronounced antiarrhythmic effects of preconditioning?

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K channels

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Association and stoichiometry of K(ATP) channel subunits

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Evidence for direct physical association between a K channel (Kir6.2) and an ATP-binding cassette protein (SUR1) which affects cellular distribution and kinetic behavior of an ATP-sensitive K channel

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Truncation of Kir6.2 produces ATP-sensitive K channels in the absence of the sulphonylurea receptor

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive K channel

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K channel

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Burst Kinetics of Co-expressed Kir6.2/SUR1 Clones: Comparison of Recombinant with Native ATP-sensitive K Channel Behavior

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

Abnormalities of pancreatic islets by targeted expression of a dominant-negative K ATP channel

1 reference

https://api.crossref.org/works/10.1016/S0735-1097(98)50038-2

7 January 2021

10.1016/S0735-1097(98)00038-2

Identifiers

DOI

1 reference

8 October 2017

1 reference